BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9493416)

  • 1. [Molecular mechanisms of chemotherapeutic resistance in genitourinary cancers].
    Kakehi Y
    Nihon Hinyokika Gakkai Zasshi; 1998 Jan; 89(1):1-13. PubMed ID: 9493416
    [No Abstract]   [Full Text] [Related]  

  • 2. [Multidrug resistance].
    Mickisch GH
    Urologe A; 1996 Sep; 35(5):370-7. PubMed ID: 8915096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligonucleotide modulation of multidrug resistance.
    Bouffard DY; Ohkawa T; Kijima H; Irie A; Suzuki T; Curcio LD; Holm PS; Sassani A; Scanlon KJ
    Eur J Cancer; 1996 Jun; 32A(6):1010-8. PubMed ID: 8763342
    [No Abstract]   [Full Text] [Related]  

  • 4. Are ABCB1 (P-glycoprotein) polymorphisms clinically relevant in ovarian cancer? - Finally an Answer!
    Konecny GE
    Gynecol Oncol; 2013 Oct; 131(1):1-2. PubMed ID: 24093937
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of an ATP-binding cassette transporter in Cryptosporidium parvum.
    Perkins ME; Volkman S; Wirth DF; Le Blancq SM
    Mol Biochem Parasitol; 1997 Jul; 87(1):117-22. PubMed ID: 9233681
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro models of multiple drug resistance.
    Greenberger LM; Cohen D; Horwitz SB
    Cancer Treat Res; 1994; 73():69-106. PubMed ID: 7710911
    [No Abstract]   [Full Text] [Related]  

  • 7. Unanswered questions about multidrug resistance.
    Beck WT
    Cytotechnology; 1996; 19(3):177-9. PubMed ID: 8862003
    [No Abstract]   [Full Text] [Related]  

  • 8. Biology of the multidrug resistance-associated protein, MRP.
    Loe DW; Deeley RG; Cole SP
    Eur J Cancer; 1996 Jun; 32A(6):945-57. PubMed ID: 8763335
    [No Abstract]   [Full Text] [Related]  

  • 9. P-glycoprotein-mediated multidrug resistance in tumor cells: biochemistry, clinical relevance and modulation.
    Shustik C; Dalton W; Gros P
    Mol Aspects Med; 1995; 16(1):1-78. PubMed ID: 7783568
    [No Abstract]   [Full Text] [Related]  

  • 10. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arabidopsis MDR genes: molecular cloning and protein chemical aspects.
    Dudler R; Sidler M
    Methods Enzymol; 1998; 292():162-73. PubMed ID: 9711552
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of gene amplification in drug resistance.
    Schoenlein PV
    Cancer Treat Res; 1994; 73():167-200. PubMed ID: 7710905
    [No Abstract]   [Full Text] [Related]  

  • 13. miRNAs for the detection of multidrug resistance: overview and perspectives.
    Gisel A; Valvano M; El Idrissi IG; Nardulli P; Azzariti A; Carrieri A; Contino M; Colabufo NA
    Molecules; 2014 Apr; 19(5):5611-23. PubMed ID: 24786846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-glycoprotein homologues.
    Buschman E; Lepage P; Gros P
    Cancer Treat Res; 1994; 73():17-39. PubMed ID: 7536017
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversing antibiotic resistance.
    Hodgkinson R; Sharples D
    Expert Opin Investig Drugs; 2002 Aug; 11(8):1023-32. PubMed ID: 12150699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genes encoding multiple drug resistance-like proteins in Aspergillus fumigatus and Aspergillus flavus.
    Tobin MB; Peery RB; Skatrud PL
    Gene; 1997 Oct; 200(1-2):11-23. PubMed ID: 9373135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of P-glycoprotein in drug resistance in multiple myeloma.
    Abraham J; Salama NN; Azab AK
    Leuk Lymphoma; 2015 Jan; 56(1):26-33. PubMed ID: 24678978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
    Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M
    Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: a potential use in intravesical chemotherapy.
    Pu YS; Hsieh TS; Cheng AL; Tseng NF; Su IJ; Hsieh CY; Lai MK; Tsai TC
    Br J Urol; 1996 Jan; 77(1):76-85. PubMed ID: 8653321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of mRNAs for apoptosis-modulating proteins in a low level multidrug resistant variant of a human lung carcinoma cell line that also expresses mdr1 mRNA.
    NicAmhlaoibh R; Heenan M; Cleary I; Touhey S; O'Loughlin C; Daly C; Nuñez G; Scanlon KJ; Clynes M
    Int J Cancer; 1999 Jul; 82(3):368-76. PubMed ID: 10399954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.